Related Experiment Video
Updated: Jul 13, 2026

Curcuminoid-Mediated Antimicrobial Photodynamic Therapy on a Murine Model of Oral Candidiasis
Published on: October 27, 2023
A comparative clinical study of sisomicin cream versus mupirocin ointment in pyodermas
Chetan Oberai1, S Shailendra, Darchan Dalal
1Dept. of Skin, STD & Leprosy, Grant Medical College & Sir J. J. Group of Hospitals J. J. Road, Byculla, Mumbai, India.
Abstract:
This study was designed to compare the efficacy and safety of sisomicin cream (0.1%) or mupirocin ointment (2%) in the treatment of primary or secondary pyodermas requiring topical antibiotic therapy alone. In the evaluable patients (n=290), impetigo was the commonest clinical condition reported. Staphylococcus aureus was the commonest pathogen isolated from the lesions. Both sisomicin and mupirocin treatments produced a steady improvement in the scores of erythema, oedema, vesiculation, pustulation, crusting and scaling but the improvement produced by sisomicin was quicker and more pronounced. The percentage of patients with complete clearing of all lesions was also higher with sisomicin than with mupirocin on days 4, 8 and 14. Patients subjectively rated the sisomicin formulation as excellent in 75% of cases as against 59% with mupirocin. Sisomicin and mupirocin are effective and safe in the management of pyodermas; however sisomicin therapy resulted in faster and greater relief of signs and symptoms.
Insights
Sisomicin cream demonstrated faster and more significant improvement in pyoderma symptoms compared to mupirocin ointment. Both topical antibiotics were effective and safe for treating skin infections.
Area of Science:
- Dermatology
- Infectious Diseases
- Pharmacology
Background:
- Pyodermas are common bacterial skin infections.
- Topical antibiotics are a standard treatment for pyodermas.
- Sisomicin and mupirocin are commonly used topical antibiotics.
Purpose of the Study:
- To compare the efficacy and safety of sisomicin cream versus mupirocin ointment for pyoderma treatment.
- To evaluate the speed and degree of symptom improvement.
- To assess patient-reported outcomes.
Main Methods:
- A comparative study involving 290 evaluable patients with primary or secondary pyodermas.
- Treatment with either sisomicin cream (0.1%) or mupirocin ointment (2%).
- Assessment of clinical signs (erythema, oedema, etc.) and pathogen eradication.
Main Results:
- Both treatments improved clinical scores, with sisomicin showing quicker and more pronounced effects.
- Higher rates of complete lesion clearing were observed with sisomicin on days 4, 8, and 14.
- Sisomicin was rated excellent by 75% of patients, versus 59% for mupirocin.
Conclusions:
- Sisomicin and mupirocin are effective and safe topical treatments for pyodermas.
- Sisomicin therapy offers faster and more substantial relief from signs and symptoms.
- Sisomicin may be a preferred option for pyoderma management due to superior clinical outcomes.
Related Concept Videos
Staphylococcal Skin Infections
Hand hygiene
Hand washing...
Clinical Significance of Antibiotic Resistance
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...